These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3276824)
1. Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study. Perloff M; Lesnick GJ; Korzun A; Chu F; Holland JF; Thirlwell MP; Ellison RR; Carey RW; Leone L; Weinberg V J Clin Oncol; 1988 Feb; 6(2):261-9. PubMed ID: 3276824 [TBL] [Abstract][Full Text] [Related]
2. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. Griem KL; Henderson IC; Gelman R; Ascoli D; Silver B; Recht A; Goodman RL; Hellman S; Harris JR J Clin Oncol; 1987 Oct; 5(10):1546-55. PubMed ID: 3309196 [TBL] [Abstract][Full Text] [Related]
3. Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B. Aisner J; Weinberg V; Perloff M; Weiss R; Perry M; Korzun A; Ginsberg S; Holland JF J Clin Oncol; 1987 Oct; 5(10):1523-33. PubMed ID: 3655855 [TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer. Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517 [TBL] [Abstract][Full Text] [Related]
5. The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group. Olson JE; Neuberg D; Pandya KJ; Richter MP; Solin LJ; Gilchrist KW; Tormey DC; Veeder M; Falkson G Cancer; 1997 Mar; 79(6):1138-49. PubMed ID: 9070491 [TBL] [Abstract][Full Text] [Related]
6. Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experience. Koh EH; Buzdar AU; Ames FC; Singletary SE; McNeese MD; Frye D; Holmes FA; Fraschini G; Hug V; Theriault RL Cancer Chemother Pharmacol; 1990; 27(2):94-100. PubMed ID: 2249339 [TBL] [Abstract][Full Text] [Related]
8. Combined chemotherapy and radiotherapy for patients with breast cancer and extensive nodal involvement. Ung O; Langlands AO; Barraclough B; Boyages J J Clin Oncol; 1995 Feb; 13(2):435-43. PubMed ID: 7844606 [TBL] [Abstract][Full Text] [Related]
9. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience. Brito RA; Valero V; Buzdar AU; Booser DJ; Ames F; Strom E; Ross M; Theriault RL; Frye D; Kau SW; Asmar L; McNeese M; Singletary SE; Hortobagyi GN J Clin Oncol; 2001 Feb; 19(3):628-33. PubMed ID: 11157012 [TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281. Aisner J; Cirrincione C; Perloff M; Perry M; Budman D; Abrams J; Panasci L; Muss H; Citron M; Holland J J Clin Oncol; 1995 Jun; 13(6):1443-52. PubMed ID: 7751891 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study. Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501 [TBL] [Abstract][Full Text] [Related]
12. Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center. Ueno NT; Buzdar AU; Singletary SE; Ames FC; McNeese MD; Holmes FA; Theriault RL; Strom EA; Wasaff BJ; Asmar L; Frye D; Hortobagyi GN Cancer Chemother Pharmacol; 1997; 40(4):321-9. PubMed ID: 9225950 [TBL] [Abstract][Full Text] [Related]
13. A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer. A Cancer and Leukemia Group B study. Tormey DC; Weinberg VE; Leone LA; Glidewell OJ; Perloff M; Kennedy BJ; Cortes E; Silver RT; Weiss RB; Aisner J Am J Clin Oncol; 1984 Jun; 7(3):231-9. PubMed ID: 6375344 [TBL] [Abstract][Full Text] [Related]
14. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients. Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040 [TBL] [Abstract][Full Text] [Related]
15. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients]. Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583 [TBL] [Abstract][Full Text] [Related]
16. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. Overgaard M; Hansen PS; Overgaard J; Rose C; Andersson M; Bach F; Kjaer M; Gadeberg CC; Mouridsen HT; Jensen MB; Zedeler K N Engl J Med; 1997 Oct; 337(14):949-55. PubMed ID: 9395428 [TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Swain SM; Sorace RA; Bagley CS; Danforth DN; Bader J; Wesley MN; Steinberg SM; Lippman ME Cancer Res; 1987 Jul; 47(14):3889-94. PubMed ID: 3036348 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of nodal involvement region in clinical stage IIIc breast cancer patients who received primary systemic treatment, surgery, and radiotherapy. Noh JM; Kim KH; Park W; Suh CO; Huh SJ; Choi DH; Keum KC; Kim YB Breast; 2015 Oct; 24(5):637-41. PubMed ID: 26283599 [TBL] [Abstract][Full Text] [Related]
19. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer. Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215 [TBL] [Abstract][Full Text] [Related]
20. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]